Menu
 

Search abstracts


Bioequivalence study of oseltamivir phosphate capsules

  • At: 2007 FIP Congress in Beijing (China)
  • Type: Poster
  • By: CHEN, Xiaoyan (Institute of Materia Medica, Shanghai, China)
  • Co-author(s): Dai, Xiaojian (Institute of Materia Medica, SHANGHAI, China)
    Zhong, Dafang (Institute of Materia Medica, SHANGHAI, China)
    Chen, Wangsheng (Shanghai Changzheng Hospital, SHANGHAI, China)
  • Abstract:

    OBJECTIVE A study was conducted to establish the bioequivalence between a newly developed Oseltamivir Phosphate Capsules (as the test formulation, Shanghai Sunve Pharmaceutical Co., Ltd, China) and TamifluÂ[RSYMBOL] (as the reference formulation, Roche, Switzerland). METHODS The clinical investigation was designed as a randomized, open-labelled ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses